Innovations in Parkinson’s Diagnosis

REGISTER HERE for the November Parkinson’s Spotlight Webinar – Innovations in Parkinson’s Diagnosis

Join us on November 5, 2025, from 12-1pm PT/3-4pm ET to learn from Todd D. Levine, MD, Chief Medical Officer and Co-Founder of CND Life Sciences who will discuss the Syn-One Test®, a groundbreaking diagnostic tool that uses skin biopsies to detect abnormal alpha-synuclein, the protein linked to Parkinson’s disease and related conditions. Dr. Levine will also share insights on what’s on the horizon for future diagnostic developments and what this could mean for earlier detection, more accurate diagnoses, and improved care for people living with Parkinson’s..

Presenter bio:

Dr. Todd Levine is one of the three founders of CND Life Sciences and serves as its Chief Medical Officer, playing a key role in the delivery of diagnostic services and ongoing technology development. Dr. Levine also serves as the Director of Neuroscience Research at HonorHealth Research Institute and has over 25 years of experience as a clinical neurologist with a sub-specialty in disorders of the peripheral nervous system. In 2010, he founded his first medical diagnostics company called Corinthian Reference Lab (CRL). Based in Fort Worth, Texas, CRL has processed over 50,000 skin biopsies, receiving specimens from over 4,000 different neurologists across the US and Canada. He received his medical degree from Duke University and did his residency and fellowship at Washington University in St Louis. He has served as the Chairman of the Neuromuscular Division of the American Academy of Neurology and has served as the Medical Director of Neurology for HonorHealth in Phoenix, Arizona.